Loading...
Recurrent retroperitoneal soft tissue sarcoma showing drastic reduction after pazopanib administration accompanied by severe liver dysfunction
Pazopanib is an orally bioavailable tyrosine kinase inhibitor anticancer drug approved worldwide for the treatment of metastatic renal cell carcinoma and advanced soft tissue sarcoma. Here we report the case of a patient whose recurrent retroperitoneal soft tissue sarcoma showed a drastic reduction...
Na minha lista:
| Udgivet i: | Urol Case Rep |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6041368/ https://ncbi.nlm.nih.gov/pubmed/30003043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2018.05.018 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|